Gergis Explains the Differences Between Acute and Chronic GVHD
Usama Gergis, MD, MBA, reviewed that difference in acute and chronic graft-versus-host disease and the treatment available for each
A 61-Year-Old Man With Acute Graft-Versus-Host Disease
Usama Gergis, MD, presents the case of a 61-year old man with GvHD, and provides an overview of available treatment options for similar patients, with consideration of the REACH1, REACH2, and GRAVITAS-301 trial regimens.
The Future of GVHD Management
Phase 3 Trials: REACH2 and GRAVITAS-301
REACH1 Regimen: Steroid Combination and Adverse Events
Phase 2 REACH1 Overview
Steroid-Dependent Versus Steroid-Refractory Graft-Versus-Host Disease
A 61-Year-Old Man With Graft-Versus-Host Disease